Using evidence in practice: Foot care in diabetes

Endocrinology and Metabolism Clinics of North America

Volumn 31, Issue 3, 2002, Pages 603-611

  Hunt, Dereck ^a,b  

^a MCMASTER UNIVERSITY   (Canada)

^b HENDERSON GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; ARGINYLGLYCYLASPARTIC ACID; GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR;

AMPUTATION; CLINICAL TRIAL; DIABETES MELLITUS; DIABETIC FOOT; EDUCATION PROGRAM; FIBROBLAST; FOOT ULCER; HUMAN; HYPERBARIC OXYGEN; MULTICENTER STUDY; PATHOPHYSIOLOGY; PATIENT EDUCATION; PRIORITY JOURNAL; REVIEW; RISK FACTOR; ULCER HEALING;

DIABETIC FOOT; EVIDENCE-BASED MEDICINE; HUMANS; RISK FACTORS;

EID: 0036714689     PISSN: 08898529     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8529(02)00022-1     Document Type: Review

References (31)

1. A prospective study of risk factors for diabetic foot ulcer: The Seattle diabetic foot study
2. Diabetes and nontraumatic lower extremity amputations: Incidence, risk factors, and prevention: A 12 year follow-up study in Nauru
3. Lower-extremity amputation: Incidence, risk factors, and mortality in the Oklahoma Indian diabetes study
4. Risk factors predicting lower extremity amputations in patients with NIDDM
5. The prevalence and incidence of lower extremity amputation in a diabetic population
6. Long-term incidence of lower-extremity amputations in a diabetic population
7. Lower-extremity amputations in NIDDM: 12 Year follow-up study in Pima Indians
8. Identifying diabetic patients at high risk for lower-extremity amputation in a primary health care setting
9. The risk of foot ulceration in diabetic patients with high foot pressure: A prospective study
10. The prediction of diabetic neuropathic foot ulceration using vibration perception thresholds: A prospective study
11. Health-related quality of life in patients with diabetes mellitus and foot ulcers
12. Incidence, outcomes, and cost of foot ulcers in patients with diabetes
13. A systematic review of foot ulcer in patients with Type 2 diabetes mellltus. I: Prevention
14. Evaluation of a diabetic foot screening and protection programme
15. Reduction of lower extremity clinical abnormalities in patients with non-insulin-dependent diabetes mellitus
16. Manufactured shoes in the prevention of diabetic foot ulcers
17. Prevention of amputation by diabetic education
18. A systematic review of foot ulcer in patients with Type 2 diabetes mellitus. II: Treatment
19. Total contact casting in treatment of diabetic plantar ulcers: Controlled clinical trial
20. Effectiveness and safety of a nonremovable fiberglass off-bearing cast versus a therapeutic shoe in the treatment of neuropathic foot ulcers: A randomized study
21. Off-loading the diabetic foot wound: A randomized clinical trial
22. Use of dermagraft, a cultured human dermis, to treat diabetic foot ulcers
23. A metabolically active human dermal replacement for the treatment of diabetic foot ulcers
24. Clinical evaluation of recombinant human platelet-derived growth factor for the treatment of lower extremity diabetic ulcers
25. Efficacy and safety of a topical gel formulation of recombinant human platelet-derived growth factor-BB (Becaplermin) in patients with chronic neuropathic diabetic ulcers
26. Promotion and acceleration of diabetic ulcer healing by arginine-glycine-aspartic acid (RGD) peptide matrix
27. A randomized controlled dose response trial of activated platelet supernatant, topical CT-102 in chronic, non-healing diabetic wounds
28. Graftskin, a human skin equivalent, is effective in the management of noninfected neuropathic diabetic foot ulcers: A prospective randomized multicenter clinical trial
29. Adjunctive systemic hyperbaric oxygen therapy in treatment of severe prevalently ischemic diabetic foot ulcer
30. Hyperbaric oxygen therapy in diabetic foot
31. Antibiotic treatment for uncomplicated neuropathic forefoot ulcers in diabetes: A controlled trial